Terns Pharmaceuticals, Inc. (TERN)

CIK 1831363 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Terns Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jun 5, 2026SCHEDULE 13G/A0000895421-26-000192
May 15, 202615-12G0001193125-26-225474
May 13, 2026SCHEDULE 13G/A0000919574-26-002934
May 12, 2026SCHEDULE 13G/A0000895421-26-000162
May 7, 2026EFFECT9999999995-26-001530
May 5, 202640001799780-26-000004
May 5, 202640001403571-26-000004
May 5, 202640001872564-26-000010
May 5, 202640001656998-26-000006
May 5, 2026S-8 POS0001193125-26-205368
May 5, 2026S-8 POS0001193125-26-205373
May 5, 2026POSASR0001193125-26-205348
May 5, 2026S-8 POS0001193125-26-205382
May 5, 20268-K0001193125-26-205305
May 5, 202640001563623-26-000004
May 5, 2026SC TO-T/A0001193125-26-205232
May 5, 2026S-8 POS0001193125-26-205357
May 5, 2026S-8 POS0001193125-26-205386
May 5, 2026S-8 POS0001193125-26-205362
May 5, 2026S-8 POS0001193125-26-205393
May 5, 2026S-8 POS0001193125-26-205399
May 5, 2026S-8 POS0001193125-26-205366
May 5, 202625-NSE0001354457-26-000405
May 5, 2026SC 14D9/A0001193125-26-205293
May 5, 2026POS AM0001193125-26-205352